Briacell Long Term Debt To Capitalization from 2010 to 2024

BCTX Stock  USD 0.54  0.02  3.41%   
Briacell Therapeutics Long Term Debt To Capitalization yearly trend continues to be fairly stable with very little volatility. Long Term Debt To Capitalization will likely drop to 0.0004 in 2024. During the period from 2010 to 2024, Briacell Therapeutics Long Term Debt To Capitalization regression line of annual values had r-squared of  0.33 and arithmetic mean of  0.0004. View All Fundamentals
 
Long Term Debt To Capitalization  
First Reported
2010-12-31
Previous Quarter
0.000408
Current Value
0.000363
Quarterly Volatility
0.00002543
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Briacell Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Briacell Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 86.7 K, Interest Expense of 0.0 or Other Operating Expenses of 34.4 M, as well as many indicators such as Price To Sales Ratio of 0.0, Days Sales Outstanding of 0.0 or Invested Capital of 622.1 K. Briacell financial statements analysis is a perfect complement when working with Briacell Therapeutics Valuation or Volatility modules.
  
Check out the analysis of Briacell Therapeutics Correlation against competitors.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Briacell Stock Analysis

When running Briacell Therapeutics' price analysis, check to measure Briacell Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Briacell Therapeutics is operating at the current time. Most of Briacell Therapeutics' value examination focuses on studying past and present price action to predict the probability of Briacell Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Briacell Therapeutics' price. Additionally, you may evaluate how the addition of Briacell Therapeutics to your portfolios can decrease your overall portfolio volatility.